1. From the Department of Molecular and Cell Biology, Roswell Park Cancer Institute, Buffalo, NY; University of Cambridge, Cambridge Institute for Medical Research, Cambridge, UK; Pfizer Central Research, the Department of Genomics, Targets and Cancer, Groton, CT; and the Departments of Human Genetics and Ophthalmology, University of Pittsburgh, Pittsburgh, PA.